A molecular signaling map and its application

Cellular Signalling

Volumn 26, Issue 12, 2014, Pages 2834-2842

  Li, Jian ^a,b   Mansmann, Ulrich R ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer hallmark; Comparative flux analysis; Drug discovery; Molecular modeling; Signaling pathway; Targeted therapy

Indexed keywords

ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; DRUG RESEARCH; DRUG RESPONSE; FEEDBACK SYSTEM; MOLECULAR SIGNALING MAP; MOLECULARLY TARGETED THERAPY; PREDICTION; PRIORITY JOURNAL; RISK REDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; DRUG EFFECTS; HUMAN; METABOLISM; NEOPLASM; TUMOR CELL LINE;

ANIMALIA;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84928267717     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.08.022     Document Type: Article

References (49)

1. R. Hyduke, A. Amundson, Fornace Jr., in: R.A. bradshow, E.A. Dennis (Eds.),Handbook of Cell Signaling, 3, 2009, pp. 2107-2125
2. Carter G.W., Prinz S., Neou C., Shelby J.P., Marzolf B., Thorsson V., Galitski T. Mol. Syst. Biol. 2007, 3:96.
3. Lemmon M.A., Schlessinger J. Cell 2010, 141:1117-1134.
4. Witsch E., Sela M., Yarden Y. Physiology (Bethesda) 2010, 25:85-101.
5. Hynes N.E., MacDonald G. Curr. Opin. Cell Biol. 2009, 21:177-184.
6. Perona R. Clin. Transl. Oncol. 2006, 8:77-82.
7. Johnson J.I., et al. Br. J. Cancer 2001, 84:1424-1431.
8. Voskoglou-Nomikos T., Pater J.L., Seymour L. Clin. Cancer Res. 2003, 9:4227-4239.
9. Amit I., Citri A., Shay T., Lu Y., Katz M., Zhang F., Tarcic G., Siwak D., Lahad J., Jacob-Hirsch J., et al. Nat. Genet. 2007, 39:503-512.
10. Oda K., Matsuoka Y., Funahashi A., Kitano H. Mol. Syst. Biol. 2005, 1. (2005.0010).
11. Wang J., Lu M., Qiu C.X., Cui Q.H. Nucleic Acids Res. 2010, 38(Database issue):D119-D122.
12. Dweep H., Sticht C., Pandey P., Gretz N. J. Biomed. Inform. 2011, 44. (839-7).
13. Li J., Mansmann U. PLoS ONE 2013, 8(8):e72477. 10.1371/journal.pone.0072477.
14. Hanahan D., Weinberg R.A. Cell 2011, 144:646-674.
15. Moustakas A., Souchelnytskyi S., Heldin C.H. J. Cell Sci. 2001, 114:4359-4369.
16. Ulloa L., Doody J., Massague J. Nature 1999, 397.
17. Blackburn E.H., Greider C.W., Szostak J.W. Nat. Med. 2006, 12:1133-1138.
18. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H.W., Dhingra U., Sokoloski J.A., Hsiao R., Narayanan R. Proc. Natl. Acad. Sci. 1996, 93:6091-6095.
19. Vasiliou V., Vasiliou K., Nebert D.W. Hum. Genomics 2009, 3(3):281-290.
20. Fong W.G., Liston P., Rajcan-Separovic E., St Jean M., Craig C., Korneluk R.G. Genomics 2000, 70(1):113-122.
21. Cheng T. Oncogene 2004, 23:7256-7266.
22. Steinman R. Oncogene 2002, 21(21):3403-3413.
23. Evan G.I., Vousden K.H. Nature 2001, 411:342-348.
24. Wittke U.Z., Simon H.U. Cell Death Differ. 2001, 8(5):537-544.
25. Holbeck S., Collins J.M., Doroshow J.H. Mol. Cancer Ther. 2010, 9:1451-1460.
26. Fingar D.C., Richardson C.J., Tee A.R., Cheatham L., Tsou C., Blenis J. Mol. Cell. Biol. 2004, 24(1):200-216.
27. Proud C.G., Wang X. Physiology 2006, 21:362-369.
28. Hung C.M., Garcia-Haro L., Sparks C.A., Guertin D.A. Cold Spring Harb. Perspect. Biol. 2012, 4(12). (pii: a008771).
29. Raymond E., Faivre S., Armand J.P. Drugs 2000, 60(1):15-23.
30. Roskoski R. Biochem. Biophys. Commun. 2004, 324(4):1155-1164.
31. Li X., Shen Y., Ichikawa H., Antes T., Goldberg G.S. Oncogene 2009, 28(48):4272-4283.
32. Quintavalle M., Elia L., Condorelli G., Courtneidge S.A. J. Cell Biol. 2010, 189(1):13-22.
33. Caron E., Ghosh S., Matsuoka Y., Ashton-Beaucage D., Therrien M., Lemieux S., Perreault C., Roux P., Kitano H. Mol. Syst. Biol. 2008, 6:453.
34. Li F., Thiele I., Jamshidi N., Pallson B. PLoS Comput. Biol. 2009, 5(2). (e1000292).
35. Fisher R., Pusztai L., Swanton C. Br. J. Cancer 2013, 108:479-485.
36. Karaman M.W., Herrgard S., Treiber D.K., Gallant P., Atteridge C.E., Campbell B.T., Chan K.W., Ciceri P., Davis M.I., Edeen P.T., Faraoni R., Floyd M., Hunt J.P., Lockhart D.J., Milanov Z.V., Morrison M.J., Pallares G., Patel H.K., Pritchard S., Wodicka L.M., Zarrinkar P.P. Nat. Biotechnol. 2008, 26(1):127-132.
37. http://discover.nci.nih.gov/datasets.jsp.
38. http://discover.nci.nih.gov/cellminer.
39. Cohen M.H., William G.A., Shridhara R., Chen G., Pazdur R. Oncologist 2003, 8:303-306.
40. Fry D.W., et al. Mol. Cancer Ther. 2004, 3:1427-1438.
41. Johnson J.R., et al. Clin. Cancer Res. 2005, 11:6414-6421.
42. Nelson M.H., Dolder C.R. Ann. Pharmacother. 2006, 40:261-269.
43. Goodman V.L., Rock E.P., Dagher R., Ramchandant R., Abraham S., Gobburu J., Booth B.P., Verbois L., Morse D.E., Liang C., Chidambaram N., Jiang J.X., Tang S.H., Mahjoob K., Justice R., Pazdur R. Clin. Cancer Res. 2007, 13:1367.
44. Agarwala S.S., Case S. Oncologist 2010, 15(3):236-245.
45. Araujo J., Logothetis C. Cancer Treat. Rev. 2010, 36(6):492-500.
46. Kwitkowski V.E., Prowell T.M., Ibrahlm A., Farrell A.T., Justice R., Mitchell S.S., Sridhara R., Pazdur R. Oncologist 2010, 15(4):428-435.
47. Sebolt-Leopold J.S., English J.M. Nature 2006, 441. 10.1038/nature04874.
48. Clopper C.J., Pearson E.S. Biometrika 1934, 26:404-413.
49. ftp://138.245.80.137/msm.xml.